CV Lattes
Universidade de São Paulo (USP). Faculdade de Medicina de Ribeirão Preto (FMRP) (Institutional affiliation from the last research proposal) Birthplace: Brazil
Currently is a post-doctoral at Innate Immunity and Microbial Pathogenicity Lab - FMRP/USP, under supervision of Prof. Dr. Dario S. Zamboni, where she works with High Content Screening of Active Compounds against Leishmania. Currently involved in in vitro infection projects with SARS-CoV-2 and samples from COVID-19 patients. Studying MBA in Business Management at USP/ESALQ. She had PhD in Biotechnology by the Universidade Estadual Paulista - Julio Mesquita Filho - Unesp, at this time she worked on the project entitled "Leishmaniasis and furoxan and benzofuroxan derivatives: in vitro and in vivo biological activity, mechanisms of action and potential therapeutic targets." Held internship in Glagow with Jeremy Mottram and Graham Coombs, at the University of Glasgow and the University of Strathclyde. Master's degree in Pharmaceutical Sciences by the Federal University of Alfenas in 2013, where she also worked on projects with Leishmania and Leishmaniasis. Graduated in Biotechnology by this same university (Universidade Federal de Alfenas - 2010). (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Leishmania amazonensis is one of the Leishmania species that cause leishmaniasis in Brazil, an endemic disease present in several countries. The disease can cause death and is considered by the World Health Organization a neglected tropical disease. Currently available treatments are expensive, long-lasting, and offer cardiac, hepatic and renal risks to those infected. In some cases, trea…
| 1 / 1 | Completed scholarships in Brazil |
| Associated processes | |